E
Sell
9/5/2023Downgrade
Carmell Therapeutics Corporation (CTCX) was downgraded to E+ from D- on 9/5/2023 due to a decline in the total return index, volatility index and valuation index.
D
Sell
8/21/2023Upgraded
Carmell Therapeutics Corporation (CTCX) was upgraded to D- from E+ on 8/21/2023 due to a noticeable increase in the solvency index and valuation index.
E
Sell
7/28/2023None
Longevity Health Holdings, Inc. (XAGE) was downgraded to E+ from U on 07/28/2023.
